PIVKA-II as a Serological Marker of Hepatocellular Carcinoma

Articles

Page Path

Editorial

PIVKA-II as a Serological Marker of Hepatocellular Carcinoma

Sook-Hyang Jeong

CMH 2006;12(3):315-317.

Author Affiliations

Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea

3,381 Views
24 Download
0 Crossref
0 Scopus

prev next

Full Article

Download PDF

Keywords: Hepatocellular carcinoma; Tumor marker; PIVKA-II (Protein induced by vitamin K absence or antagonist-II); Des-gamma-carboxy prothrombin (DCP); alpha-Fetoprotein

Citations

Citations to this article as recorded by

Cite

CITE

export

Copy Download

Format

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

PIVKA-II as a Serological Marker of Hepatocellular Carcinoma

Korean J Hepatol. 2006;12(3):315-317.

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
bib — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

PIVKA-II as a Serological Marker of Hepatocellular Carcinoma

Korean J Hepatol. 2006;12(3):315-317.

Articles

Page Path

PIVKA-II as a Serological Marker of Hepatocellular Carcinoma

Full Article

Citations

CITE

Download Citation

Format:

Include:

Related articles

ABOUT

BROWSE ARTICLES

FOR CONTRIBUTORS